The Prevalence of Metabolic Syndrome Among Older Adults in Ecuador: Results of the SABE Survey
Overview
Affiliations
Aims: To describe the prevalence of metabolic syndrome among older adults in Ecuador. A secondary objective was to examine the relationship between metabolic syndrome and its components and insulin resistance among non-diabetic participants.
Materials And Methods: The National Survey of Health, Wellbeing, and Aging survey was used to examine the prevalence of metabolic syndrome according to demographic, behavioral, and health characteristics of the participants. Logistic regression models adjusted for covariates were used to examine the independent association of metabolic syndrome and its components and insulin resistance in non-diabetic older adults.
Results: Of 2298 participants with a mean age of 71.6 (SD 8.1) years, the prevalence of metabolic syndrome was 66.0% (95% CI, 62.6%, 69.3%) in women and 47.1% (95% CI, 43.2%, 50.9) in men. However, even higher prevalence rates were seen among literate individuals, residents from urban areas of the coastal and Andes Mountains region, obese subjects, those diagnosed with diabetes, and participants with≥2 comorbidities. Overall, abdominal obesity followed by elevated blood pressure were the metabolic syndrome components more prevalent and associated with insulin resistance among older Ecuadorians. Moreover, after adjustment for covariates, older adults defined as having metabolic syndrome had a 3-fold higher odds of having insulin resistance as compared with those without.
Conclusions: The prevalence of metabolic syndrome is high among older adults in Ecuador. The present findings may assist public health authorities to implement programs of lifestyle and behavioral modification targeting older adults at increased risk for this cardio metabolic disorder.
Dai D, Zhao L, Li S, Xu Y, Du A Aging Clin Exp Res. 2025; 37(1):54.
PMID: 40011300 PMC: 11865104. DOI: 10.1007/s40520-025-02984-y.
Zila-Velasque J, Grados-Espinoza P, Challapa-Mamani M, Sanchez-Alcantara F, Cedillo-Balcazar J, Cs A Sci Rep. 2024; 14(1):27581.
PMID: 39528530 PMC: 11555074. DOI: 10.1038/s41598-024-77928-z.
Hashemi R, Rabizadeh S, Yadegar A, Mohammadi F, Rajab A, Karimpour Reyhan S BMC Geriatr. 2024; 24(1):873.
PMID: 39448921 PMC: 11515473. DOI: 10.1186/s12877-024-05483-3.
Incidence and long-term specific mortality trends of metabolic syndrome in the United States.
Li W, Qiu X, Ma H, Geng Q Front Endocrinol (Lausanne). 2023; 13:1029736.
PMID: 36733801 PMC: 9886893. DOI: 10.3389/fendo.2022.1029736.
Yu S, Guo X, Li G, Yang H, Zheng L, Sun Y Front Cardiovasc Med. 2022; 9:995128.
PMID: 36505366 PMC: 9726899. DOI: 10.3389/fcvm.2022.995128.